Quest Diagnostics, Inc. (DGX) Posts Mixed Q2 Results; Guides FY11 EPS In-Line
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Price: $125.91 --0%
Revenue Growth %: -1.7%
Financial Fact:
Selling, general and administrative: 409M
Today's EPS Names:
MAXN, CSTR, ACU, More
Revenue Growth %: -1.7%
Financial Fact:
Selling, general and administrative: 409M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Quest Diagnostics, Inc. (NYSE: DGX) reported Q2 adjusted EPS of $1.17, $0.04 better than the analyst estimate of $1.13. Revenue for the quarter came in at $1.9 million versus the consensus estimate of $1.92 billion.
Quest Diagnostics, Inc. sees FY2011 EPS of $4.25-$4.35, versus the consensus of $4.33.
Quest Diagnostics, Inc. sees FY2011 EPS of $4.25-$4.35, versus the consensus of $4.33.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- American Express (AXP) down despite beating Q1 estimates on top and bottom lines
- PPG Industries (PPG) Reports In-Line Q1 EPS, offers outlook
- Procter & Gamble (PG) Tops Q3 EPS by 11c, Revenues Miss
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
